Home > Quotes > GSK

GlaxoSmithKline PLC Stock Quote & Summary Data

GSK 
$46.45
*  
0.07
0.15%
Get GSK Alerts
*Delayed - data as of Nov. 28, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
1 Year Target: 56.5
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 4,888,687
Previous Close: $ 46.52
52 Week High /Low: $ 56.73 / $ 41.91
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 111,572,900,000
P/E Ratio: 16.41
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 15.20
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 2.83
Annualized dividend $ 2.4521
Ex Dividend Date Nov. 5, 2014
Dividend Payment Date Jan. 8, 2015
Current Yield 5.27 %
Beta 0.59

Intraday Chart

ETFs with GSK as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.82% Merrill Lynch Pharmaceutical HOLDRS (PPH) +4.33  (7.03%)
3.29% FlexShares International Quality Dividend Defensive Index Fund (IQDE) -2.28  (-8.08%)
1.69% iShares iBonds Mar 2016 Corporate ex-Financials Term ETF (IBCB) -0.44  (-0.44%)
1.62% FlexShares International Quality Dividend Index Fund (IQDF) -2.20  (-7.65%)
0.61% FlexShares Morningstar Developed Markets ex-US Factor Tilt Ind (TLTD) -4.54  (-6.85%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

• “Our CEO’s Review of the year” on pages 4 and 5 (excluding the information in the first paragraph under the heading “Outlook” on page 5); • “Business overview” on pages 6 and 7 • “The global context” on pages 8 to 11; • “Our business model” on pages 12 and 13; • “Our strategic priorities “ on pages 14 and 15, (excluding the information in the first paragraph under the heading “Outlook” on page 15); • “How we performed” on pages 16 and 17; • “Risk management,” “Global risk management” and “Risk management within the business” on pages 18 and 19; • “Deliver” on pages 32 and 33; • “Pipeline progress” o  ... More ...  

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?